Chennai, India based B2B platform PepPill Stock has secured $150K (₹1.125 Crore) through “Microsoft for Startups” accelerator program.
PepPill Stock is eCommerce B2B platform for pharmacies to procure their supply available in Web (PepPill Stock Web Portal)
and Android App. The Portal and App makes it easy for pharmacy owners to order all items in one place and manage the purchase orders from anywhere. It helps them to keep a track of the demand and make quick purchase decisions. PepPill Stock delivers the products at transparent prices and assured delivery times.
PepPill Stock is a B2B solution that brings digital procurement services for retail pharmacists with broader coverage and availability. The pharmacy owners can purchase their medicines anytime, anywhere. Pharmacists can check out the list of alternate medicines available, along with medicinal composition, manufacturer, and other details. Additionally, they can note down out-of-stock items, order them directly. Attractive discounts and exciting cashback schemes are available to high-volume customers. Pharmacy owners can search their purchase orders and invoices using a wide range of filters and get a quick glimpse of the payment status and payment dues.
Quality pharmacy procurement enables business at fingertips and insights that helps to understand inventory requirements and industry trends. “The Startup program is offering various software and Azure credit worth up to $150,000 over the next 12-18 months,” said Palani Perumal, PepPill Stock’ Founder & CEO. Microsoft’s cloud computing service, Azure, allows companies to build, deploy and manage applications using Microsoft-managed servers.
“We are super excited to be part of Microsoft for Startups program and this approval reinforces the program’s confidence in PepPill Stock’ potential, and the impact technology can have in Pharmacy Procurement. The program benefits spanning technology and marketing helps us to expand platform capabilities and reach more customers effectively. We have planned to add more capabilities using Machine Learning, AI, and add analytical capabilities to the platform that can bring in significant value creation to pharmacy business in India,” adds Palani.
Palani describes this strategic deal with Microsoft as a particularly key step in our journey to be effective in healthcare using technology. It will enable the product to explore new directions and help to change pharmacy procurement experience in India. He adds that this ₹1.125 Crore would be useful to develop an AI-based inventory management and demand planning system, to predict what medicines to procure and how much to procure, and to help pharmacies optimize their inventory. The partnership provides PepPill Stock a streamlined path to connect with leading enterprises while capitalizing on Microsoft’s vast sales network.